[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.211.117. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 23, 1991

Evaluation of Neuroleptic Drug Use by Nursing Home Elderly Under Proposed Medicare and Medicaid Regulations

Author Affiliations

From the Division of Health Services Research and Policy, School of Public Health (Drs Garrard and Kane), the Department of Applied Statistics, School of Statistics (Mr Makris), the Department of Educational Psychology, College of Education (Ms Dunham), the Department of Pharmacy Practice, College of Pharmacy, and the Department of Clinical Pharmacy, St Paul-Ramsey Medical Center, St Paul, Minn (Ms Cooper), the Abbott Northwestern Hospital, Minneapolis, Minn (Dr Ratner), and the Division of Biostatistics, School of Public Health (Dr Zelterman), University of Minnesota, Minneapolis; and The Washington Institute for Mental Illness Training and Research, University of Washington, Seattle (Dr Heston).

From the Division of Health Services Research and Policy, School of Public Health (Drs Garrard and Kane), the Department of Applied Statistics, School of Statistics (Mr Makris), the Department of Educational Psychology, College of Education (Ms Dunham), the Department of Pharmacy Practice, College of Pharmacy, and the Department of Clinical Pharmacy, St Paul-Ramsey Medical Center, St Paul, Minn (Ms Cooper), the Abbott Northwestern Hospital, Minneapolis, Minn (Dr Ratner), and the Division of Biostatistics, School of Public Health (Dr Zelterman), University of Minnesota, Minneapolis; and The Washington Institute for Mental Illness Training and Research, University of Washington, Seattle (Dr Heston).

JAMA. 1991;265(4):463-467. doi:10.1001/jama.1991.03460040039025
Abstract

Federal regulations for use of neuroleptic drugs in Medicare- and Medicaidcertified nursing homes throughout the United States were implemented October 1,1990. These regulations constitute the first time that prescription drugs are required, by law, to be justified by indications documented in the medical chart. This study used extant data to estimate ineligible neuroleptic use at the individual and nursing home levels had these regulations been in effect in 1976 through 1985. Subjects, randomly sampled admissions (N = 5752) and residents (N = 3191), were followed up for up to 24 months in 60 nursing homes. One half of neuroleptic use in each cohort could be considered ineligible under the regulations; all but one of the nursing homes had one or more individuals who were treated with the ineligible use of neuroleptics. Improvements in documentation and/or prescription of neuroleptic drugs for nursing home elderly will be needed to ensure compliance with these new regulations.

(JAMA. 1991;265:463-467)

×